OBI-1

BIOLOGICAL3 trials

Sponsors

Baxalta now part of Shire

Conditions

Acquired Hemophilia AHemophilia A

Phase 2

Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Acquired Hemophilia A

CompletedNCT01178294

Baxalta now part of ShireAcquired Hemophilia A

Start: 2010-11-10End: 2013-10-09Updated: 2021-05-13

Phase 3

Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Congenital Hemophilia A

TerminatedNCT01434511

Baxalta now part of ShireHemophilia A

Start: 2011-10-03End: 2013-07-29Updated: 2021-05-14

Unknown Phase

Expanded Access to B-Domain Deleted Recombinant Porcine Factor VIII (OBI-1) in the Treatment of Acquired Hemophilia A Due to Factor VIII Inhibitory Auto-antibodies

Baxalta now part of ShireAcquired Hemophilia A

Updated: 2021-05-05

Related Papers

Real-world use of recombinant porcine sequence factor VIII in the treatment of acquired hemophilia A: EU PASS.

2024-09-02

Efficacy and safety of recombinant porcine factor VIII in Japanese patients with acquired hemophilia A

International Journal of Hematology2024-08-193 citations